The genus Ebolavirus belongs to the family Filoviridae and order Mononegavirales, where the members of this genus are called ebolaviruses[@b1]. The Ebolavirus (EBOV, formerly designated "Zaire ebolavirus") is one of the five known Ebolaviruses. EBOV cause Ebolavirus disease (EVD) in humans and other mammals. EVD is a type of hemorrhagic fever having a high case fatality rate[@b2]. From March 2014 to October 2014, the Ebola outbreak in West Africa has sickened 8,399 people, killing 4,033 of them[@b3]. This is the largest EBOV outbreak in the history[@b4]. Each month, several thousand people from affected areas travel to the North America, and even more travellers enter and leave Europe, other parts of Africa, and Asia[@b5]. Such air travel situations increase the possibility of EVD transmission. The United States and France have reported that several patients tested positive for Ebola[@b3][@b4][@b5][@b6]. Moreover, no current antiviral medications are available for EBOV[@b7], and no effective EVD treatment exists at this time[@b8].

MicroRNAs (miRNAs) are small regulatory non-coding RNAs, ranging from 19 to 24 nucleotides, that post-transcriptionally regulate target gene expression by inhibiting the translation of mRNA transcripts or cleaving them[@b9][@b10][@b11][@b12]. While encoded not only by cellular genomes but also by viral genomes[@b13][@b14][@b15], miRNAs play a vital role in numerous cellular processes, including cell metabolism, viral infection, and antiviral immune response[@b16][@b17]. Viral miRNAs are mostly identified by traditional cloning from virus-infected cells[@b18][@b19][@b20]. Computational prediction and hybridization analysis are also applied to viral miRNA identification[@b21][@b22]. For known viral miRNAs, the majority of them are encoded by DNA viruses while only a few derived from RNA viruses[@b23][@b24]. To date, the RNA virus-encoded miRNAs have been identified in a few retroviruses including bovine leukemia vius (BLV)[@b25][@b26], human immunodeficiency virus (HIV)[@b25], West Nile virus (WNV)[@b27], Dengue virus[@b28] and hepatitis A virus (HAV)[@b23]. Recently, Liang *et al.*[@b24] have identified two EBOV miRNAs, which means that EBOV can encode functional miRNAs.

Unlike the method used by Liang *et al.*[@b24], based on bioinformatics whole genome-wide scanning and screening, we predicted the potential mature 2014 EBOV miRNAs, their target genes, and related signaling pathways. To the best of our knowledge, this is the first paper to systemic genome-wide analyze and predict the potential non-coding RNAs in the 2014 outbreak EBOVs along with their target genes. The results show several target genes regulated by the possible miRNAs may have important functions in human immune and antiviral response systems. Our research helps to further assess the roles of the 2014 outbreak EBOV miRNAs and their potential targets during viral infection and virus-host interactions, and thus to speed up the process of effective EVD treatment development.

Results
=======

Alignment of EBOV whole genomes and prediction of mature EBOV miRNAs
--------------------------------------------------------------------

As shown in [Fig. 1A](#f1){ref-type="fig"}, we first aligned the complete genome sequences of the 102 human EBOV strains acquired from the 2014 outbreak[@b29]. The mutation sites were all highlighted in different colors[@b30]. Four real microRNA precursor candidates, with the names of EBOV-pre-miRNA-T1, EBOV-pre-miRNA-T2, EBOV-pre-miRNA-T3 and EBOV-pre-miRNA-T4, were picked out. Their sequences are listed in [Table 1](#t1){ref-type="table"}. EBOV-pre-miRNA-T1 is 136-base long, EBOV-pre-miRNA-T2 is 80-base long, EBOV-pre-miRNA-T3 is 99-base long, and EBOV-pre-miRNA-T4 is 99-base long. Their locations were marked in [Fig. 1B](#f1){ref-type="fig"}. The start position of EBOV-pre-miRNA-T1 is 653, while its end position is 788. EBOV-pre-miRNA-T2 is located between the position of 4373 and of 4452. EBOV-pre-miRNA-T3 is at the range between 488 and 586. EBOV-pre-miRNA-T4 is located from the position of 479 to 568. Seven different mature EBOV miRNA candidates were predicted using the four EBOV miRNA precursor candidates. The sequences of the eight mature EBOV miRNAs are listed in [Table 2](#t2){ref-type="table"}, where EBV-miR-T3-5p has the same sequence with EBV-miR-T4-5p. Their lengths are all 22-base long. By aligning and blasting the seven miRNAs, including EBV-miR-T1-5p, EBV-miR-T1-3p, EBV-miR-T2-5p, EBV-miR-T2-3p, EBV-miR-T3-5p, EBV-miR-T3-3p, EBV-miR-T4-5p and EBV-miR-T4-3p, to other species of viral or host miRNAs, only EBV-miR-T3-5p has some similar miRNAs. We analyzed the conservation between EBV-miR-T3-5p and its similar miRNAs, which is described in the [Table 3](#t3){ref-type="table"}. A flowchart describing the computational prediction of the putative miRNAs is shown in [Fig. 2](#f2){ref-type="fig"}.

Structures of potential EBOV pre-miRNAs and mature miRNAs
---------------------------------------------------------

In order to achieve more accurate prediction, we predicted the primary, secondary, and tertiary structure of the four potential EBOV pre-miRNAs[@b31][@b32]. RNAfold was used to predict consensus secondary structures of the pre-miRNAs. Attempts to fold these pre-miRNAs, along with their flanking sequences, into the expected hairpin structures were successful in candidates EBOV-pre-miRNAs-T1, EBOV-pre-miRNAs-T2, EBOV-pre-miRNAs-T3 and EBOV-pre-miRNAs-T4, while other pre-miRNAs failed to fold into any form of stable RNA structures because that they could only give rise to stem-loops that were too short to be authentic pre-miRNA stem-loops. These findings led us to believe that EBOV-pre-miRNAs-T1, EBOV-pre-miRNAs-T2, EBOV-pre-miRNAs-T3 and EBOV-pre-miRNAs-T4 are indeed authentic EBOV pre-miRNAs. The optimal secondary structures in dot-bracket notation with a minimum free energy of −39.4 kcal/mol of EBOV-pre-miRNA-T1, −18.8 kcal/mol of EBOV-pre-miRNA-T2, −33.51 kcal/mol of EBOV-pre-miRNA-T3 and −31.91 kcal/mol of EBOV-pre-miRNA-T4 are given in [Fig. 3A,B](#f3){ref-type="fig"} shows the predicted hairpin structures of confirmed EBOV pre-miRNAs. Hairpins longer than 100 nt were truncated; these hairpins are indicated by a double slash preceding the stem. Furthermore, the 3D structures of the potential EBOV pre-miRNAs were computationally predicted. Even though EBOV-pre-miRNA-T3 and EBOV-pre-miRNA-T4 have similar 2D structures[@b31], they own different 3D structures ([Fig. 3C](#f3){ref-type="fig"}). The positions of possible mature miRNAs were colored in second and tertiary structures ([Figs. 3B,C](#f3){ref-type="fig"})[@b32]. For EBOV-pre-miRNAs-T1, EBOV-pre-miRNAs-T2, EBOV-pre-miRNAs-T3 and EBOV-pre-miRNAs-T4 alternative predictions, which are likely to represent the authentic stem-loop structures recognized and cleaved by Drosha are shown underneath the minimal energy structures.

Bioinformatics analysis of mature EBOV miRNAs and prediction of their target genes
----------------------------------------------------------------------------------

Based on the sequences of the seven EBOV miRNAs, EBV-miR-T1-5p, EBV-miR-T1-3p, EBV-miR-T2-5p, EBV-miR-T2-3p, EBV-miR-T3-5p, EBV-miR-T3-3p, EBV-miR-T4-5p and EBV-miR-T4-3p, their target genes were searched by TargetScan[@b33] and the other miRNA regulation database (the integration database of miRecords, TarBase, starbase, and miR2Disease)[@b34][@b35][@b36][@b37]. All these potential mature miRNAs have total 138 possible target genes in human genome ([Table 4](#t4){ref-type="table"}). Interestingly, the genes P11, EFNA3, FKRP, AMBRA1, HEPACAM, HCCA2, LPHN1 and PHF21B were all targeted by at least two potential mature EBOV miRNAs.

Using the GO and DAVID databases[@b38][@b39], identified proteins were clustered into groups based on their biological processes, molecular function, and cellular compartment. Such clustering allowed us to determine how the differentially expressed proteins were distributed according to biological process ([Fig. 4A](#f4){ref-type="fig"}), molecular function ([Fig. 4B](#f4){ref-type="fig"}) and cellular compartment ([Fig. 4C](#f4){ref-type="fig"}). Clusters with the biological process included proteins that are involved in immune system process (GO:0002376), multicellular organismal process (GO:0032501) and response to stimulus (GO:0050896), which are important for human antiviral response ([Fig. 4A](#f4){ref-type="fig"}). This analysis grouped proteins into nine molecular functional classes ([Fig. 4B](#f4){ref-type="fig"}), which were associated with transcription regulation, such as transporter activity (GO:0005215), translation regulator activity (GO:0045182), protein binding transcription factor activity (GO:0000988) and enzyme regulator activity (GO:0030234). Protein clusters were then further categorized into six subcellular distributions according to the cellular compartment ([Fig. 4C](#f4){ref-type="fig"}). [Fig. 4D](#f4){ref-type="fig"} shows the pathway enrichment analysis of the target genes. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was performed using the DAVID bioinformatics tool[@b40][@b41]. The top enriched pathways are listed here (p-value \< 0.01). [Fig. 4D](#f4){ref-type="fig"} clearly shows that these proteins are functionally closely related, and are involved in multiple pathways. Inflammation are mediated by chemokine and cytokine signaling pathway (P00031), PDGF signaling pathway (P00047), Purine metabolism (P02769), PI3 kinase pathway (P00048) and Ras Pathway (P04393), which are important in human immune response to virus infection.

The gene regulation network (GRN) of the target genes[@b42][@b43] is shown in the [Fig. 4E](#f4){ref-type="fig"}. We find that the possible target genes, HDAC5 and JARID2[@b44], are important epigenetic factors in transcription regulation, which have strong interaction with the transcription regulator in human cells, such as Histone h3, STAT1, CTCF, CCND2 and CTCF. It is illustrated that the EBOV down-regulated the epigenetic factor to large-scale epigenetic alterations in the host gene expressions[@b45], which will damage the normal molecular regulation in immune signaling and thus disorder human immune system to block the anti-viral response. The target proteins, NFKBIE and RIPK, are the key co-regulator with IL22 and IFNG or the part of complex of NFκB in human immune system[@b46][@b47]. It also suggests that the EBOV affects the signaling pathway of immune system by the non-coding RNA to inhibit the infection response. Further network analysis was conducted to see the potential biological pathways and processes in which these differentially expressed proteins were involved. In addition, [Fig. 4F](#f4){ref-type="fig"} illustrates the detail information of target genes which play key roles in important immune and epigenetic responses.

Signaling pathway analysis of the target genes
----------------------------------------------

According to our gene regulation network analysis, NFKBIE and RIPK1 are two target genes of possible mature miRNAs, EBOV-miR-T1-5p and EBOV-miR-T2-3p, which plays important roles in immune system. [Fig. 5A,B](#f5){ref-type="fig"} show the cytotoxin-associated target genes. NFKBIE[@b48] and RIPK[@b49] genes are both involved in the NF-κB and TNF signaling pathways ([Fig. 5C,D](#f5){ref-type="fig"}). NFKBIE encodes IκB epsilon (IκBε), a member of the IκB family. Its binding to NF-κB inhibits the nuclear translocation of NF-κB[@b50]. RIPK1, Receptor-interacting protein 1, is a key effector molecule in the TNFα-induced activation of the transcription factor NF-κB[@b51]. The signaling pathway analysis shows that the TNF-a--mediated NF-kB signaling pathway plays a key role in inflammatory response ([Fig. 5C,D](#f5){ref-type="fig"}). Through analyzing the molecular mechanism in the NF-kB and TNF signaling pathways, those two pathways were discovered to participate in the host immune response, thus they are also attractive targets of viral pathogens[@b52]. The EBOV coding possible miRNAs, EBOV-miR-T1-5p and EBOV-miR-T2-3p, may be silence and down-regulate the NFKBIE and RIPK1, which are the central mediator of those pathways. In addition, the EBOV exploits the non-coding RNA to inhibit the NF-kB and TNF factor to evade the host defense mechanisms that limit replication by killing infected cells, or to conversely trigger apoptosis as a mechanism to increase virus spreading. NF-kB is activated by multiple families of viruses, including HIV-1, HTLV-1, hepatitis B virus (HBV), hepatitis C virus (HCV), EBV, and influenza virus[@b53]. This activation may serve several functions of promoting viral replication, preventing virus-induced apoptosis, and suprressing the immune response to the invading pathogen[@b54]. The genes NF-kB and TNF are affected by synthetic dsRNAs. It suggests that viruses that generate dsRNA replicative intermediates employ a common mechanism to enhance viral replication. The EBOV glycoprotein (GP) and the other viral proteins also induce the NF-kB and TNF signaling pathways[@b55]. The miRNA and target gene details of EBV-miR-T1-5p and EBV-miR-T2-3p are listed in [Fig. 5E](#f5){ref-type="fig"}. The target gene of EBV-miR-T1-5p is named NFKBIE with ID No. 4794, and 1053-bp long. The target gene of EBV-miR-T2-3p is named RIPK1 with ID No. 8737, and 1848-bp long. Normally when a virus enters a human body, the target genes mentioned above should increase their expression levels. Based on our analysis, once EBOV enters the human body, the miRNAs EBV-miR-T1-5p and EBV-miR-T2-3p down-regulate the target genes of NFKBIE and RIPK1 to evade host innate immune responses and finally leads to multiple organ dysfunction syndrome (MODS).

EBOV miRNA regulated the expression of target genes NFKIBIE, RIPIK1, HDAC5 and JARID2
-------------------------------------------------------------------------------------

The miRNA mimics was synthesized and transfected into Hela cells for 24 h/37 °C. The results showed that EBOV-miRNA mimics directly regulate the expression of target genes, NFKIBIE, RIPIK1, JARID2 and HDAC5, in Hela cells. Real time (RT)-PCR was used to quantify and compare the mRNA expression of target genes in the transfected Hela cells with the EBOV-miRNA mimics and the scramble mimics as negative control. The transfection efficiency of miRNA mimics, including miR-T1-3p, miR-T2-5p, miR-T3-3p, miR-T4-3p and their mixed miRNA (MIX miRNA), and the scrambled miRNA mimics were detected by fluorescence activated cell sorter (FACS), which were more than 80% ([Fig. 6A](#f6){ref-type="fig"}). The RT-PCR analysis indicated that expression of NFKIBIE was significantly down-regulated by 1.526 times in miR-T1-5p mimics-transfected Hela cells and the expression of RIPIK1 and JARID2 were down-regulated by miR-T2-3p mimics with 1.947 times and 2.25 times separately ([Fig. 6B](#f6){ref-type="fig"}). Interestingly, in the transfected Hela cells with miR-T3-5p mimics, the expression of HDAC5 is increasing compared with the transfected Hela cells with scrambled miRNA mimics ([Fig. 6B](#f6){ref-type="fig"}). We also found that the mRNA expression of NFKIBIE were inhibited by miR-T1-3p, miR-T3-5p, miR-T4-3p and MIX miRNA mimics, while all EBOV-miRNA mimics significantly can block the expression of RIPK1 ([Fig. 6C](#f6){ref-type="fig"}). Such results illustrated that these miRNA may have important functions in human immune and antiviral response systems.

Conclusion
==========

From March 2014 to October 2014, the largest EBOV outbreak in the history has killed several thousand people in West Africa, yet no current specific treatment is validated for EBOV. miRNAs has been demonstrated to circulate in a highly stable, cell-free form in body fluids thus circulating miRNAs can be used as non-invasive biomarkers for molecular diagnostics and prognostics[@b24]. Since the majority of known viral miRNAs are encoded by DNA viruses, RNA-virus-encoded miRNAs remains controversial. Recently, despite that several novel miRNAs have been experimentally identified in the West Nile virus (WNV)[@b28], Dengue virus (DENV)[@b56], hepatitis A virus (HAV)[@b23], the viral miRNAs in numerous viruses have been identified using computational prediction followed by experimental validation[@b23][@b57][@b58][@b59]. This year H. Liang *et al.*[@b24] have successfully identified two EBOV miRNAs, which provide new evidence that EBOV can encode functional miRNAs.

In this paper, based on the whole genome alignment of the 2014 outbreak EBOVs[@b29], which is different from the analysis method of Liang *et al.*[@b24], we predicted and experimentally verified seven mature EBOV miRNAs and their regulated target genes. By analyzing the signaling pathways of the target genes, we hypothesized that EBOV miRNAs, especially EBV-miR-T1-5p and EBV-miR-T2-3p, down-regulate the target genes of NF-KB and TNF expression which are involved in virus-cell interaction, immune escape, and cell apoptosis[@b48][@b49]. As viruses evolve under the highly selective pressures of the immune system, they acquire the capacity to target critical steps in the host cell life, hijacking vital cellular functions to promote viral pathogenesis. Many viruses have evolved mechanisms to target the NF-kB pathway to facilitate their replication, cell survival, and evasion of immune responses. In addition, some viruses use the NF-kB pathway either for its anti-apoptotic properties to evade the host defense mechanisms or to trigger apoptosis as a mechanism of virus spread. Not surprisingly, recent studies focusing on the interrelations between NF-kB and virus pathogenesis reveal that many viral products bypass signal-induced stimulation and/or receptor-proximal steps to directly interface with the IKK complex. Continuous activation of NF-kB as a consequence of viral persistence in some instances leads to oncogenic transformation, which is an area of increasing scientific study and fascination.

It is noteworthy that this is the first paper to describe a strategy that the EBOV non-coding RNA may be evolved to modulate the NF-kB and TNF signaling pathways, to enhance viral replication, host cell survival, and evasion of immune responses. According to our prediction results, the EBOV-miRNA mimics of miR-T1-5p can significantly inhibit the expression of NFKIBIE, while the miR-T2-3p mimics can block the expression of RIPK1 significantly.

Such results illustrated that these miRNA may have important functions in human immune and antiviral response systems. Ongoing research will undoubtedly continue to reveal other novel interactions between viruses and the NF-kB pathway that will permit a more precise molecular dissection of this parasitic fatal attraction. Considering that the target genes regulated by our predicted miRNAs play key roles in human immune response, we highlight our prediction work raises the hope of quickly finding an effective EBOV disease treatment.

Materials and Methods
=====================

EBOV whole genome sequencing
----------------------------

To show the genome-wide nucleotide and amino acid signatures, we retrieved full genome sequences (as of October 22, 2014) from the genome browser at NCBI Database. One-hundread-and-two human EBOV genomes were derived from the 2014 outbreak[@b29][@b30].

Multiple genome-wide alignments
-------------------------------

The multiple sequence alignment tools ClustalW and MUSCLE were applied for the alignment of the EBOV genomes. The alignments were then analyzed to identify the characteristic sites as potential signatures to distinguish different virus genomes and proteins[@b30].

Bioinformatics prediction of the miRNAs
---------------------------------------

A flowchart describing the computational prediction of the putative miRNAs is shown in [Fig. 2](#f2){ref-type="fig"}. Briefly, the viral genome was scanned for stem-loop structures of miRNA precursor (pre-miRNA) using VMir[@b60] ([http://www.hpi-hamburg.de/research/ departments-and-research-groups/antiviral-defense-mechanism/software-down- load.html](http://www.hpi-hamburg.de/research/departments-and-research-groups/antiviral-defense-mechanism/software-down-load.html)), a computational analyzer program for the prediction of putative pre-miRNAs. The complete genome sequences of 138 different human EBOV strains were acquired from the PubMed, where 102 human EBOV strains belong to 2014 EBOV outbreak. VMir predictions were carried out using the default parameters. The putative pre-miRNAs that satisfied the filter parameters of a VMir score ≥150 and a window count ≥35 were selected for further assessment. Then, the source code of MiPred[@b61] was used to distinguish real and pseudo miRNA precursors from the obtained sequences with a prediction confidence equal to or greater than 70%. Subsequently, mature miRNA sequences were predicted from the pre-miRNA stem-loops. Then we used the MatureBayes tool[@b62] to extend the prediction coverage of the mature miRNAs. The default conditions were used for the MatureBayes tool.

Prediction of Novel Viral miRNA Targets
---------------------------------------

Human target genes of novel EBOV miRNAs were predicted using TargetScan[@b33] custom miRNA prediction methods. Putative targets within the viral genome were predicted using TargetScan Perl script[@b34][@b36][@b37][@b60].

Gene ontology (GO) analysis
---------------------------

GO analysis of the significant probe list was performed using PANTHER (<http://www.pantherdb.org/>)[@b38][@b39], using text files containing the Gene ID list and accession numbers of the Illumina probe ID. All data analysis and visualization of differentially expressed genes were conducted using R 2.4.1 ([www.r-project.org](http://www.r-project.org)). In addition, the DAVID Functional Annotation Bioinformatics Microarray Analysis tools (<http://david.abcc.ncifcrf.gov/>) were used to study the biological function of the regulated genes.

Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis
---------------------------------------------------------------

Kyoto Encyclopedia of Genes and Genomes (KEGG)[@b40][@b41] is a collection of online databases dealing with genomes, enzymatic pathways, and biological chemicals. The PATHWAY database records networks of molecular interactions in the cell that includes organism-specific network maps (<http://www.genome.jp/kegg/>). A total of 9 pathways, involving 49 genes, were collected from KEGG.

Constructing Gene Regulation Network
------------------------------------

The integrated regulatory network was constructed based on systematic integration of various high-throughput datasets[@b42][@b43]. The target genes associated with candidate miRNAs were selected from miRNA regulation database (the integration database of miRecords, TarBase, starbase, and miR2Disease) and TFs associated with those target genes were selected from Transcriptional Regulatory Element Database (TRED). The integrated target genes-TF regulatory network was constructed by using Cytoscape software (<http://cytoscape.org/>), which is an open source software for visualizing complex networks and integrating these networks with any type of attribute data.

Cell culture and transfection
-----------------------------

Hela cells at 37 °C and 5% CO~2~ in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Hyclone, USA) . Synthetic duplex EBV-miRNA mimics, scramble oligonucleotides used as negative control (NC) (GenePharma, Shanghai, China) at a final concentration of 50 nM were introduced into Hela cells by siPORT™ NeoFX™ transfection agent (AM4511, Applied Biosystems Inc., USA). according to the manufacturer's instructions. Cells were harvested at 24 hours after transfection.

RNA extraction and quantitative real-time PCR analysis
------------------------------------------------------

The harvested cells were placed in TRIzolH Reagent (Invitrogen, Carlsbad,CA), and total RNAs were extracted according to the TRIzol manufacturer'sinstructions. Total RNA (3 μg) was primed by oilgodT and converted intocDNA using SuperScript III (Invitrogen). The SYBR green-based real-time PCR was performed in Light Cycle 2.0 System(Roche) and Relative quantification of mRNA was measured using 2-ΔΔCt method which normalized to GAPDH. Each PCR assay was performed in a final volume of 20 ul, containing 2 ul of DNA template, 25 pmol of each type-specific primer set, 2X Maxima SYBR Green (Thermo Scientific), Reactions were incubated at 50 °C for2 minutes, followed by PCR amplification under the following conditions: 95 °C for10 minutes, 95 °C for 30 seconds, 57 °C for 30 seconds, 72 °C for 30 minute for a total of 40 cycles, Following the PCR step, a melt curve analysis was performed by increasing the temperature from 65 °C to 95 °C at increments of 0.1 °C/s for each fluorescence reading. The primer sequences for qPCR analysis were as follows: GAPDH, forward 5′-AGAAGGCTGGGGCTCATTTG-3′ and reverse 5′- AGGGGCCATCCACAGTCTTC-5′; NFKBIE, forward 5′- TGCCAACAGATGGCCCATAC-3′ and reverse 5′- TGTTCTTTTCACTAGAGGCACCA-3′; RIPK1, forward 5′-TGGGCGTCATCATGAGGAAG-3′ and reverse 5′-CGCCTTTTCCATGTAAGTAGCA-3′ ; MAPKAP3, forward 5′- ATGAGAACATGCACCATGGCAAGC-3′ and reverse 5′- GGGCAATGTTATGGCTGTGCAGAA -3′; HDAC5, forward 5′- TTCTTTGGACCAGAGTTCCC-3′ and reverse 5′- GTTGGGTTCAGAGGCTGTTT-3′; JARID2, forward 5′- GAGCATGTGTTTCAGCAAGG-3′ and reverse 5′- CTTCTCTTCCACTAGCCTCCAG-3′

Flow cytometry
--------------

Green fluorescence after fluorescent dye labeled miRNA delivery into Hela cells were assessed in an Accuri C6 BD Biosciences flow cytometer, excited by an argon 480 nm laser and detected by use of a 520 nm optical filter. The mean fluorescence intensity (MFI) data were collected from these cell populations. All data was analyzed with a minimum of 15000 events setting the respective negative control to less than 1% in BD CFlow software. Post-transfection in Hela cells as percentage of fluorescent dye labeled miRNA positive cells.
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![The 102 complete genome sequences alignment of the 2014 outbreak EBOV. (**A**) Full alignment map of all 102 EBOV complete genomes. (**B**) Locations and putative target sites of the four real miRNA precursor candidates.](srep09912-f1){#f1}

![Workflow of the 2014 outbreak EBOV-encoded miRNA prediction. The MiPred algorithm was used to identify genuine pre-miRNAs, and the MatureBayes tool was used to predict the mature miRNA sequences.](srep09912-f2){#f2}

![Predicted hairpin structures of potential EBOV pre-miRNAs. (**A**) The primary structures of the four EBOV pre-miRNAs. (**B**) The secondary structures of the four EBOV pre-miRNAs. (**C**) The tertiary structures of the four EBOV pre-miRNAs.](srep09912-f3){#f3}

![Bioinformatic analysis of target gene prediction and related signaling pathways of the potential mature miRNAs in EBOV. The predicted target gene of potential mature EBOV miRNAs were classified by the GO and DAVID databases based on biological process (**A**), molecular function (**B**) and cellular compartment (**C**). (**D**) The pathway enrichment analysis of candidate genes. Top enriched pathways are listed (*p value* \< 0.01). (**E**) The gene regulation network analysis of the potential target genes. (**F**) The detail information of target genes of miRNA EBV-miR-T3-5p, EBV-miR-T2-3p, EBV-miR-T2-3p and EBV-miR-T2-5p.](srep09912-f4){#f4}

![Signaling pathway analysis of the potential mature EBOV miRNA target genes. (**A**) The associated genes of Edema, □-kappaB kinase/ NF-kappaB cascade and replication of virus. (**B**) The associated genes of cell death of kidney cell lines, failure of heart, congestive heart failure, hepatorenal syndrome and cell death of cardiomyocytes. (**B**) TNF signaling pathway. (**C**) NF-κB signaling pathway. (**D**) Detail information of target gene NFKBIE. (**E**) Detail information of target gene RIPK1.](srep09912-f5){#f5}

![Transfection efficiency of EBOV-miRNA mimics and effect of the EBOV-miRNA mimics on the expression of target genes in Hela cells. (**A**) Transfection efficiency 24 h post-transfection in Hela cells as percentage of fluorescent dye labeled miRNA positive cells. (**B**) Relative expression levels of NFKIBIE, RIPK1, HDAC5 and JARID2, which were regulated by EBOV-miRNA mimics miR-T1-5p, miR-T2-3p and miR-T3-5p, respectively. (**C**) Relative expression levels of NFKIBIE and RIPK1, which were regulated by six EBOV-miRNA mimics and their mixed miRNA (MIX miRNA). *\*: P \< 0.05, \*\*: P \< 0.01, \*\*\*: P \< 0.001. Label "NC" means negative control.*](srep09912-f6){#f6}

###### The predicted pre-miRNAs in EBOV.

  **Pre-miRNA**        **Strand**  **Start Position**   **End Position**   **Length**                                                              **Sequence (5′-3′)**
  ------------------- ------------ -------------------- ------------------ ------------ ------------------------------------------------------------------------------------------------------------------------------------------
  EBOV-pre-miRNA-T1       Plus     653                  788                136           UUGAUUUUCAAGAGAGUGCGGACAGUUUCCUUCUCAUGCUUUGUCUUCAUCAUGCGUACCAAGGAGAUUACAAACUUUUCUUGGAAAGUGGCGCAGUCAAGUAUUUGGAAGGGCACGGGUUCCGUUUUGAAGUCAA
  EBOV-pre-miRNA-T2       Plus     4373                 4452               80                                        AACCAAAAAUGAUGAAGAUUAAGAAAAACCUACCUCGACUGAGAGAGUGUUUUUUCAUUAACCUUCAUCUUGUAAACGUU
  EBOV-pre-miRNA-T3       Plus     488                  586                99                              GGAUGACGCCGAGUCUCACUGAAUCUGACAUGGAUUACCACAAGAUCUUGACAGCAGGUCUGUCCGUUCAACAGGGGAUUGUUCGGCAAAGAGUCAUCC
  EBOV-pre-miRNA-T4       Plus     479                  568                99                              GGAUGACGCCGAGUCUCACUGAAUCUGACAUGGAUUACCACAAGAUCUUGACAGCAGGUCUGUCCGUUCAACAGGGGGUUGUUCGGCAAAGAGUCAUCC

###### The predicted mature miRNAs in EBOV. The EBV-miR-T3-5p and EBV-miR-T4-6p have the same sequences, which are highlighted in grey color.
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###### Alignment of Query (EBV-miR-T3-5p) to mature miRNAs
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###### The list of possible target genes.

  **Gene Name**   **Gene ID**                                             **Human Symbol**
  --------------- ------------- ----------------------------------------------------------------------------------------------------
  ABCC13          150000                   ABCC13 (ATP-binding cassette, sub-family C (CFTR/MRP), member 13, pseudogene)
  ADNP2           22850                                               ADNP2 (ADNP homeobox 2)
  ADRA2B          151                                              ADRA2B (adrenoceptor alpha 2B)
  ADTRP           84830                                  ADTRP (androgen-dependent TFPI-regulating protein)
  AHR             196                                             AHR (aryl hydrocarbon receptor)
  ALDH3B1         221                                   ALDH3B1 (aldehyde dehydrogenase 3 family, member B1)
  AMBRA1          55626                                       AMBRA1 (autophagy/beclin-1 regulator 1)
  AMICA1          120425                             AMICA1 (adhesion molecule, interacts with CXADR antigen 1)
  ARFIP1          27236                                ARFIP1 (ADP-ribosylation factor interacting protein 1)
  ARHGAP27        201176                                    ARHGAP27 (Rho GTPase activating protein 27)
  ATXN10          25814                                                  ATXN10 (ataxin 10)
  BEST4           266675                                                BEST4 (bestrophin 4)
  C2orf27A        29798                                    C2orf27A (chromosome 2 open reading frame 27A)
  CA7             766                                               CA7 (carbonic anhydrase VII)
  CA9             768                                               CA9 (carbonic anhydrase IX)
  CABP7           164633                                         CABP7 (calcium binding protein 7)
  CBX4            8535                                               CBX4 (chromobox homolog 4)
  CCL21           6366                                        CCL21 (chemokine (C-C motif) ligand 21)
  CCND2           894                                                    CCND2 (cyclin D2)
  CEP55           55165                                          CEP55 (centrosomal protein 55kDa)
  CERS3           204219                                            CERS3 (ceramide synthase 3)
  CNN2            1265                                                   CNN2 (calponin 2)
  CPSF7           79869                            CPSF7 (cleavage and polyadenylation specific factor 7, 59kDa)
  CRAMP1L         57585                                       CRAMP1L (Crm, cramped-like (Drosophila))
  CRYAA           1409                                              CRYAA (crystallin, alpha A)
  CTDSPL2         51496          CTDSPL2 (CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2)
  CYB561          1534                                                CYB561 (cytochrome b561)
  DCLK2           166614                                         DCLK2 (doublecortin-like kinase 2)
  DEAF1           10522                                          DEAF1 (DEAF1 transcription factor)
  DMWD            1762                                   DMWD (dystrophia myotonica, WD repeat containing)
  EFNA3           1944                                                   EFNA3 (ephrin-A3)
  EGFLAM          133584                           EGFLAM (EGF-like, fibronectin type III and laminin G domains)
  EIF2AK4         440275                        EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4)
  ELF3            1999                    ELF3 (E74-like factor 3 (ets domain transcription factor, epithelial-specific ))
  ELFN2           114794               ELFN2 (extracellular leucine-rich repeat and fibronectin type III domain containing 2)
  ELOVL2          54898                                         ELOVL2 (ELOVL fatty acid elongase 2)
  ENDOU           8909                                          ENDOU (endonuclease, polyU-specific)
  EVI5            7813                                       EVI5 (ecotropic viral integration site 5)
  EXOSC6          118460                                            EXOSC6 (exosome component 6)
  FAM20C          56975                                FAM20C (family with sequence similarity 20, member C)
  FAM213B         127281                              FAM213B (family with sequence similarity 213, member B)
  FASN            2194                                               FASN (fatty acid synthase)
  FBXL7           23194                                   FBXL7 (F-box and leucine-rich repeat protein 7)
  FKRP            79147                                            FKRP (fukutin related protein)
  FLJ46026        400627                                            FLJ46026 (FLJ46026 protein)
  FOXK1           221937                                              FOXK1 (forkhead box K1)
  G2E3            55632                                G2E3 (G2/M-phase specific E3 ubiquitin protein ligase)
  GCOM1           145781                                          GCOM1 (GRINL1A complex locus 1)
  GMEB2           26205                             GMEB2 (glucocorticoid modulatory element binding protein 2)
  GNAT1           2779            GNAT1 (guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1)
  GPR64           10149                                        GPR64 (G protein-coupled receptor 64)
  GRB10           2887                                    GRB10 (growth factor receptor-bound protein 10)
  GTPBP1          9567                                             GTPBP1 (GTP binding protein 1)
  HDAC5           10014                                            HDAC5 (histone deacetylase 5)
  HENMT1          113802                              HENMT1 (HEN1 methyltransferase homolog 1 (Arabidopsis))
  HEPACAM         220296                                 HEPACAM (hepatic and glial cell adhesion molecule)
  HES3            390992                                   HES3 (hes family bHLH transcription factor 3)
  JARID2          3720                                     JARID2 (jumonji, AT rich interactive domain 2)
  JRK             8629                                               JRK (Jrk homolog (mouse))
  KIAA1244        57221                                                 KIAA1244 (KIAA1244)
  KIAA1598        57698                                                 KIAA1598 (KIAA1598)
  LINGO1          84894                               LINGO1 (leucine rich repeat and Ig domain containing 1)
  LOC284395       284395                                       LOC284395 (uncharacterized LOC284395)
  LOC388022       388022                                       LOC388022 (uncharacterized LOC388022)
  LOC388942       388942                                       LOC388942 (uncharacterized LOC388942)
  LOC401134       401134                                       LOC401134 (uncharacterized LOC401134)
  LOC440600       440600                                       LOC440600 (uncharacterized LOC440600)
  LOC441455       441455                                LOC441455 (makorin ring finger protein 1 pseudogene)
  LPGAT1          9926                                  LPGAT1 (lysophosphatidylglycerol acyltransferase 1)
  LPHN1           22859                                                LPHN1 (latrophilin 1)
  LRRC27          80313                                      LRRC27 (leucine rich repeat containing 27)
  MAPKAPK3        7867                         MAPKAPK3 (mitogen-activated protein kinase-activated protein kinase 3)
  MBIP            51562                                     MBIP (MAP3K12 binding inhibitory protein 1)
  MMP25           64386                                          MMP25 (matrix metallopeptidase 25)
  MOB2            81532                                            MOB2 (MOB kinase activator 2)
  MOB3A           126308                                          MOB3A (MOB kinase activator 3A)
  MOB3B           79817                                           MOB3B (MOB kinase activator 3B)
  MRE11A          4361                           MRE11A (MRE11 meiotic recombination 11 homolog A (S. cerevisiae))
  MTMR11          10903                                       MTMR11 (myotubularin related protein 11)
  MTMR6           9107                                         MTMR6 (myotubularin related protein 6)
  MUM1            84939                                    MUM1 (melanoma associated antigen (mutated) 1)
  MVB12B          89853                                       MVB12B (multivesicular body subunit 12B)
  NAP1L4          4676                                     NAP1L4 (nucleosome assembly protein 1-like 4)
  NFKBIE          4794             NFKBIE (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon)
  NLGN4X          57502                                           NLGN4X (neuroligin 4, X-linked)
  NPLOC4          55666                           NPLOC4 (nuclear protein localization 4 homolog (S. cerevisiae))
  NT5E            4907                                          NT5E (5′-nucleotidase, ecto (CD73))
  NUBP2           10101                                         NUBP2 (nucleotide binding protein 2)
  PAQR4           124222                               PAQR4 (progestin and adipoQ receptor family member IV)
  PBXIP1          57326                             PBXIP1 (pre-B-cell leukemia homeobox interacting protein 1)
  PDPK1           5170                                 PDPK1 (3-phosphoinositide dependent protein kinase 1)
  PHF20           51230                                            PHF20 (PHD finger protein 20)
  PHF21B          112885                                          PHF21B (PHD finger protein 21B)
  POLR2M          81488                              POLR2M (polymerase (RNA) II (DNA directed) polypeptide M)
  PPP4C           5531                                    PPP4C (protein phosphatase 4, catalytic subunit)
  PRKAB2          5565                          PRKAB2 (protein kinase, AMP-activated, beta 2 non-catalytic subunit)
  PRKY            5616                                      PRKY (protein kinase, Y-linked, pseudogene)
  PTPRT           11122                                PTPRT (protein tyrosine phosphatase, receptor type, T)
  RABEP1          9135                                RABEP1 (rabaptin, RAB GTPase binding effector protein 1)
  RAPH1           65059                       RAPH1 (Ras association (RalGDS/AF-6) and pleckstrin homology domains 1)
  RBM15B          29890                                        RBM15B (RNA binding motif protein 15B)
  RBMS3           27303                           RBMS3 (RNA binding motif, single stranded interacting protein 3)
  RECQL5          9400                                              RECQL5 (RecQ protein-like 5)
  RHBDL1          9028                                     RHBDL1 (rhomboid, veinlet-like 1 (Drosophila))
  RIPK1           8737                            RIPK1 (receptor (TNFRSF)-interacting serine-threonine kinase 1)
  RNF185          91445                                           RNF185 (ring finger protein 185)
  RNF31           55072                                            RNF31 (ring finger protein 31)
  S100A10         6281                                       S100A10 (S100 calcium binding protein A10)
  SAMD4B          55095                                  SAMD4B (sterile alpha motif domain containing 4B)
  SCRT1           83482                                         SCRT1 (scratch family zinc finger 1)
  SELPLG          6404                                               SELPLG (selectin P ligand)
  SETD8           387893                             SETD8 (SET domain containing (lysine methyltransferase) 8)
  SGTA            6449                      SGTA (small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha)
  SLITRK1         114798                                   SLITRK1 (SLIT and NTRK-like family, member 1)
  SOCS4           122809                                     SOCS4 (suppressor of cytokine signaling 4)
  STC2            8614                                                 STC2 (stanniocalcin 2)
  SYNGR1          9145                                                SYNGR1 (synaptogyrin 1)
  TBL2            26608                                           TBL2 (transducin (beta)-like 2)
  THOC3           84321                                                THOC3 (THO complex 3)
  TM9SF4          9777                                 TM9SF4 (transmembrane 9 superfamily protein member 4)
  TMEM63A         9725                                          TMEM63A (transmembrane protein 63A)
  TRIM35          23087                                       TRIM35 (tripartite motif containing 35)
  UPP1            7378                                             UPP1 (uridine phosphorylase 1)
  USP45           85015                                       USP45 (ubiquitin specific peptidase 45)
  UTS2B           257313                                                UTS2B (urotensin 2B)
  VAX2            25806                                          VAX2 (ventral anterior homeobox 2)
  VPS37B          79720                            VPS37B (vacuolar protein sorting 37 homolog B (S. cerevisiae))
  WASF2           10163                                         WASF2 (WAS protein family, member 2)
  WFIKKN2         124857              WFIKKN2 (WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2)
  XDH             7498                                              XDH (xanthine dehydrogenase)
  YY1AP1          55249                                          YY1AP1 (YY1 associated protein 1)
  ZCCHC24         219654                                  ZCCHC24 (zinc finger, CCHC domain containing 24)
  ZFP91           80829                                          ZFP91 (ZFP91 zinc finger protein)
  ZMIZ2           83637                                      ZMIZ2 (zinc finger, MIZ-type containing 2)
  ZNF444          55311                                           ZNF444 (zinc finger protein 444)
  ZNF672          79894                                           ZNF672 (zinc finger protein 672)
  ZNF767P         79970                                 ZNF767P (zinc finger family member 767, pseudogene)
  ZNF804A         91752                                          ZNF804A (zinc finger protein 804A)

[^1]: These authors contributed equally to this work.
